Last reviewed · How we verify

NCT03485235

Effect of Dilatation and Curettage on the Endometrial Receptivity

Completed NA Last updated 28 January 2020
What this trial tests

NA trial testing D&C in Embryo Implantation in 160 participants. Completed in 10 December 2019.

Timeline
31 March 2018
Primary endpoint
1 November 2019
10 December 2019

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment160
Start date31 March 2018
Primary completion1 November 2019
Estimated completion10 December 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 25 to 35, female only, with Embryo Implantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Effect of dilatation and curettage on the endometrial receptivity and pregnancy outcome in patients with recurrent implantation failure

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of D&C

Trials testing the same drug.

Other recruiting trials for Embryo Implantation

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03485235.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing